1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Our Blog

Partnership for a Gene Therapy Clinical Trial Signed between Généthon and Children’s Hospital Boston

PDFPrintE-mail

 A Unique multicenter International Study of Gene therapy for a Rare Genetic Disease (Wiskott-Aldrich syndrome) Led in London, Paris and Boston.

Généthon, the not-for-profit biotherapy laboratory funded by the French Muscular Dystrophy Association (AFM) thanks to the donations collected during the French Telethon, and Children’s Hospital Boston announce that they have initiated a partnership to conduct a gene therapy clinical trial for Wiskott-Aldrich Syndrome (WAS).

 

Statins: Benefits Questionable in Low-Risk Patients

PDFPrintE-mail

 There is Not Enough Evidence to Recommend the Widespread use of Statins in People with no Previous History of Heart Disease, According to a New Cochrane Systematic Review.

Researchers say statins should be prescribed with caution in those at low risk of cardiovascular disease (CVD). CVD is the most common cause of death, accounting for nearly a third of all deaths worldwide. Cholesterol-lowering statins are first line treatments for heart patients and the benefits are well established.

Read Article

 

Pioneering Brain Research Launched for Coma Patients

PDFPrintE-mail

 University of Aberdeen

Pioneering brain imaging techniques are being developed by University of Aberdeen scientists to find out more about patients in a coma.The new Aberdeen Coma Science Group – the first of its kind in Scotland – will develop groundbreaking medical imaging methods for understanding the brain function of patients in a coma as well as those in a persistent vegetative state and sufferers of locked in syndrome.

Read Article

 

Zinc Reduces the Burden of the Common Cold

PDFPrintE-mail

 Zinc supplements reduce the severity and duration of illness caused by the common cold, according to a systematic review published in The Cochrane Library. The findings could help reduce the amount of time lost from work and school due to colds.

Read Article

 

Siemens Reducing Radiation Dose Through Partnership, Innovation, and Dedication

PDFPrintE-mail

Dr. Marilyn Siegel

Stories on the dangers of excess radiation exposure from various medical imaging modalities have become a staple of both academic journals and the popular press lately. “There was always an issue with radiation, but it has hit the big time now,” says Marilyn Siegel, MD, a pediatric radiologist at St. Louis Children’s Hospital in St. Louis, Missouri, USA. “The FDA [Food and Drug Administration] is now involved. All types of imaging groups have set up panels to look at this. The problem is here, and we’re going to have to deal with it.”

Read Article

 

Activinsights Teams up with CRDM to Create Health Measurement Instrument of the Future

PDFPrintE-mail

 CRDM, the UK’s foremost provider of rapid prototyping and plastic parts production services, was tasked by ActiveInsights to help create GENEActiv 

This unique body-worn accelerometer measures and tracks everyday physical activity undertaken by a person in all environments. In 2010 designer and manufacturer of health and wellness equipment Activinsights started working on development of GENEActiv, a unique device which records information both on physical activity undertaken by a person and their environment (light and temperature) up to 100 times a second for over a week.

Read Article

 

Creabilis Announces Positive Phase IIa Results for TrkA Kinase Inhibitor CT327 in Psoriasis Vulgaris

PDFPrintE-mail

 Creabilis SA, a Clinical Stage European Biotechnology Company Addressing Unmet Medical Needs in Dermatology, has Announced Positive Results from its Phase IIa Study of its Lead Product CT327 in Psoriasis Vulgaris.

CT327 is a novel topically applied TrkA kinase inhibitor developed using Creabilis’ LSE (Low Systemic Exposure) technology. LSE technology creates new chemical entities with ideal characteristics for topical application (high local concentrations combined with low systemic exposure).

Read Article

 

Philips Multislice CT Scanners

PDFPrintE-mail

 Philips CT Scanners

For a quick path to new discoveries in clinical science or a way to enter multislice CT scanning, look to Philips CT. Philips offers advances in CT design and technology to help you see more from each day. From our most advanced Brilliance multislice scanners, which keep you at the forefront of CT imaging, to the scanners that allow you to enter the realm of multislice CT imaging with ease, Philips helps you focus on better patient care with a simpler approach. It’s the speed and performance to do more Intelligent combination of speed, power, and coverage raises the bar for advanced multislice scan.

 

Siemens Reducing Radiation Dose Through Partnership, Innovation, and Dedication

PDFPrintE-mail

  Dr. Marilyn Siegel

Stories on the dangers of excess radiation exposure from various medical imaging modalities have become a staple of both academic journals and the popular press lately. “There was always an issue with radiation, but it has hit the big time now,” says Marilyn Siegel, MD, a pediatric radiologist at St. Louis Children’s Hospital in St. Louis, Missouri, USA. “The FDA [Food and Drug Administration] is now involved. All types of imaging groups have set up panels to look at this. The problem is here, and we’re going to have to deal with it.”

Read Article

 

Philips Ingenuity CT Brings Pure Confidence

PDFPrintE-mail

 Pure confidence in action

Until now, CT scanning has too often been about tradeoffs. You’ve been forced to choose high image quality or low dose. Iterative reconstruction or speed. Well, no longer. The all-new Ingenuity CT system is so original and resourceful that it will cause you to reevaluate everything you thought you knew about low-dose imaging.

Read Article

 

Page 10 of 23

Featured Exhibitions

Featured Advertisers

 

 cardiacsci.jpg - 2.83 Kb
sonoscape.jpg 
varian.gif
aneticaid_1.gif